Show simple item record

dc.contributor.authorMylonas, AD
dc.contributor.authorBrown, AM
dc.contributor.authorCarthew, TL
dc.contributor.authorMcGrath, B
dc.contributor.authorPurdie, DM
dc.contributor.authorPandeya, N
dc.contributor.authorVecchio, PC
dc.contributor.authorCollins, LG
dc.contributor.authorGardner, ID
dc.contributor.authorde Looze, FJ
dc.contributor.authorReymond, EJ
dc.contributor.authorSuhrbier, A
dc.date.accessioned2018-05-15T04:48:42Z
dc.date.available2018-05-15T04:48:42Z
dc.date.issued2002
dc.date.modified2013-12-15T21:48:56Z
dc.identifier.issn0025-729X
dc.identifier.urihttp://hdl.handle.net/10072/54950
dc.description.abstractObjective: To describe the natural history, treatment and cost of Ross River virus-induced epidemic polyarthritis (RRV disease). Design: Questionnaire-based longitudinal prospective study. Participants and setting: Patients in the greater Brisbane area, Queensland, diagnosed with RRV disease by their general practitioners based on clinical symptoms and paired serological tests between November 1997 and April 1999. Main outcome measures: Scores on two validated quality-of-life questionnaires (Clinical Health Assessment Questionnaire and Medical Outcomes Study Short Form 36) were obtained soon after diagnosis and one, two, three, six and 12 months thereafter. Scores were compared between patients diagnosed with RRV disease alone and those with RRV disease plus other conditions. Results: 67 patients were enrolled. Most patients with RRV disease alone had severe acute symptoms, but followed a consistent path to recovery within three to six months. Other conditions, often chronic rheumatic diseases or depression, were identified in half the cohort; their quality-of-life scores suggested stable chronic illness between six and 12 months after diagnosis. Non-steroidal anti-inflammatory drugs (NSAIDs) were taken by 58% of patients (average use, 7.6 weeks; range, 2–22 weeks). Time off work averaged 1.9 days, and direct cost to the community was estimated as $A1018 per patient. Conclusions: Symptom duration and frequency of long-term symptoms may have been overestimated by previous studies of RRV disease. Disease persisting six to 12 months after RRV diagnosis was largely attributable to other conditions, highlighting the need to seek other diagnoses in RRV patients with persistent symptoms.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoeng
dc.publisherAustralasian Medical Publishing Company Pty Ltd
dc.publisher.placeAustralia
dc.publisher.urihttps://www.mja.com.au/journal/2002/177/7/natural-history-ross-river-virus-induced-epidemic-polyarthritis
dc.relation.ispartofpagefrom356
dc.relation.ispartofpageto360
dc.relation.ispartofissue7
dc.relation.ispartofjournalMedical Journal of Australia
dc.relation.ispartofvolume177
dc.subject.fieldofresearchBiomedical and clinical sciences
dc.subject.fieldofresearchPsychology
dc.subject.fieldofresearchcode32
dc.subject.fieldofresearchcode52
dc.titleNatural history of Ross River virus-induced epidemic polyarthritis.
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codec1x
dc.description.versionVersion of Record (VoR)
gro.facultyGriffith Health Faculty
gro.rights.copyrightMylonas AD, Brown AM, Carthew TL, et al. Natural history of Ross River virus-induced epidemic polyarthritis. Med J Aust 2002; 177 (7): 356-360. © Copyright 2002 The Medical Journal of Australia – reproduced with permission.
gro.date.issued2002
gro.hasfulltextFull Text
gro.griffith.authorGordon, Louisa
gro.griffith.authorReymond, Liz


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record